In medical terminology, HTS most commonly stands for hypertonic saline, a concentrated saltwater solution used to treat brain swelling, dangerously low sodium levels, and chronic lung conditions like cystic fibrosis. The abbreviation can also refer to hypertrophic scarring in dermatology or high-throughput screening in pharmaceutical research. Which meaning applies depends entirely on the clinical context, but hypertonic saline is by far the most frequent usage in hospital and emergency settings.
Hypertonic Saline: The Most Common Meaning
Normal saline, the standard IV fluid, contains 0.9% sodium chloride. Hypertonic saline is any salt solution with a concentration higher than that. In practice, the concentrations used in medicine range from 3% to 23.4%, and each serves a different purpose. The 3% concentration is the most widely studied and used, while highly concentrated forms like 23.4% are reserved for life-threatening emergencies in intensive care units.
The word “hypertonic” means the solution has a higher concentration of dissolved particles than the fluid inside your cells. When hypertonic saline enters the bloodstream, it pulls water out of swollen tissues through osmosis. This basic principle makes it valuable in several very different medical situations.
Brain Swelling and Head Injuries
The most critical use of HTS is reducing dangerous pressure inside the skull. After a severe traumatic brain injury, the brain often swells, and that swelling in an enclosed space can cause serious damage. Hypertonic saline draws excess water out of brain tissue and into the bloodstream, lowering intracranial pressure quickly.
HTS is one of two main options for this purpose, the other being a sugar-based solution called mannitol. Studies comparing the two have found that 7.5% hypertonic saline was more effective than mannitol at controlling stubborn spikes in brain pressure after severe head injuries. With 23.4% HTS (the most concentrated form), even a small volume can produce a significant pressure reduction, though results at 30, 60, and 120 minutes were similar to those achieved with mannitol.
Correcting Low Sodium Levels
Hyponatremia, or abnormally low blood sodium, can cause confusion, seizures, and in severe cases, coma. HTS at a 3% concentration is a standard treatment for raising sodium levels when they drop dangerously low. However, the correction has to happen carefully. Raising sodium too fast can damage a structure deep in the brainstem, a condition called osmotic demyelination syndrome. This is why the rate and duration of infusion are closely monitored.
The FDA label for 3% and 5% sodium chloride injections specifically warns that rapid correction of either low or high sodium is potentially dangerous and carries a risk of serious neurological complications. These solutions are also given through large veins because the high salt concentration can irritate smaller blood vessels.
Cystic Fibrosis and Airway Clearance
Outside of emergency medicine, HTS plays a completely different role for people living with cystic fibrosis (CF). Inhaling a mist of hypertonic saline through a nebulizer helps thin the thick, sticky mucus that builds up in CF airways. The salt draws water into the mucus layer, making it easier to cough up and clear out.
The Cystic Fibrosis Foundation notes that hypertonic saline is available in concentrations of 3%, 3.5%, and 7% for this purpose. The typical regimen is twice daily, and research has shown this routine reduces the number of lung infections CF patients experience. A care team tailors the exact concentration and frequency to each person’s needs.
Asthma Diagnosis
HTS also has a diagnostic use. Inhaling nebulized 4.5% saline can trigger airway narrowing in people with asthma, making it a provocation test similar to exercise challenge testing. In one study, 84% of asthmatic subjects experienced a significant drop in lung function after inhaling 4.5% saline, while healthy subjects did not. This test helps confirm an asthma diagnosis when standard testing is inconclusive.
HTS as Hypertrophic Scarring
In dermatology and plastic surgery literature, HTS often refers to hypertrophic scars, the raised, thickened scars that form after surgery, burns, or other skin injuries. These scars stay within the borders of the original wound, which is the key feature that distinguishes them from keloids. Keloids, by contrast, grow beyond the edges of the initial injury and do not improve on their own.
Hypertrophic scars typically appear within one month of an injury and begin to flatten and fade after about six months. Keloids show up around three months after injury and keep growing indefinitely. Under a microscope, the two look different as well: hypertrophic scars have fine collagen fibers arranged in an orderly, parallel pattern, while keloid collagen is thicker and arranged in random whorls. If a raised scar is improving over time, that alone suggests it is a hypertrophic scar rather than a keloid.
HTS in Drug Discovery
In pharmaceutical research, HTS stands for high-throughput screening, an automated process that tests enormous numbers of chemical compounds against a biological target to find potential new drugs. Modern HTS platforms can evaluate hundreds of thousands of compounds in a single day. Out of several hundred thousand molecules screened, typically only a few hundred “hits” emerge as candidates worth developing further. This technology replaced the older trial-and-error approach to drug discovery and is now standard practice in the pharmaceutical industry, particularly for diseases like Alzheimer’s and Parkinson’s where new treatments are urgently needed.
If you encountered the abbreviation HTS in a hospital discharge summary, lab report, or prescription, it almost certainly refers to hypertonic saline. In a dermatology note, it likely means hypertrophic scar. And in a research paper about drug development, it points to high-throughput screening. The surrounding context will always clarify which meaning applies.